SEMAGLUTIDE PROTECTS THE CARDIOVASCULAR SYSTEM Forget everything you thought you knew about weight loss medications. A sweeping new study from University College London suggests that semaglutide — the drug behind Ozempic and Wegovy — does much more than help people shed pounds. Even for patients who barely lost any weight, the risk of heart attack and stroke still dropped by a dramatic 20%. The secret? It appears that this medicine is working its magic deep inside the body, altering factors such as inflammation, blood pressure, and the health of blood vessels — benefits that extend far beyond the bathroom scale. Massive Study, Big Surprises The research, published in The Lancet and backed by Novo Nordisk, tracked more than 17,000 adults with cardiovascular disease who were overweight or obese. Half of the participants received weekly semaglutide injections, while the other half received a placebo. The result: Both groups experienced a significant difference, with those on semagl...